Searchable abstracts of presentations at key conferences in endocrinology

ea0032p92 | Bone and Osteoporosis | ECE2013

The effect of monthly Ibandronate on bone mineral density and bone turnover markers in patients with hemophilia A or B and increased risk for fracture

Anagnostis Panagiotis , Vyzantiadis Tomoleon-Achilleas , Charizopoulou Maria , Adamidou Fotini , Karras Spyridon , Slavakis Arisitidis , Garipidou Vasilia , Vakalopoulou Sofia

Introduction: Haemophilia A and B has been associated with increased prevalence of low bone mineral density (BMD). However, no study has so far evaluated the effects of anti-osteoporotic therapy on BMD.Methods/design: The primary endpoint of this prospective study was to estimate the effect of 12-month therapy of oral ibandronate 150 mg/month on BMD in patients with haemophilia A and B. Secondary endpoint was its effect on bone turnover markers (BTM), in...

ea0032p208 | Cardiovascular Endocrinology & Lipid Metabolism | ECE2013

Comparative effects of atorvastatin and rosuvastatin on vitamin D levels, glucose metabolism and systematic inflammation in non-diabetic patients with dyslipidaemia: a prospective randomised open-label study

Anagnostis Panagiotis , Adamidou Fotini , Slavakis Arisitidis , Polyzos Stergios , Panagiotou Athanasios , Selalmatzidou Despina , Karathanasi Eleni , Poulasouchidou Maria , Kita Marina

Introduction: Low levels of 25-hydroxy-vitamin D [25(OH)D] have been recognized as a new cardiovascular disease risk factor. Conflicting data exist regarding the effect of statins on 25(OH)D levels and glucose metabolism.Methods/design: This was an open-label randomized prospective comparative study evaluating the effects of atorvastatin and rosuvastatin at equivalent doses on 25(OH)D levels, glucose homeostasis and systemic inflammation in non-diabetic ...